Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,718 | -4,920 | -3,798 | -34,849 | -32,280 |
| Depreciation Amortization | 183 | 304 | 461 | 1,020 | 872 |
| Income taxes - deferred | 62 | 196 | 0 | 0 | N/A |
| Accounts receivable | 2,920 | 899 | 1,008 | 6,688 | -4,898 |
| Accounts payable and accrued liabilities | -569 | 252 | -1,683 | 1,246 | -1,939 |
| Other Working Capital | 2,367 | 1,967 | 929 | -1,231 | -5,464 |
| Other Operating Activity | -412 | -1,019 | -4,727 | 12,261 | 15,562 |
| Operating Cash Flow | $-7,168 | $-2,323 | $-7,809 | $-14,865 | $-28,146 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 3,131 | 44 |
| PPE Investments | -81 | 67 | 1,688 | -375 | -1,029 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -7,000 |
| Investing Cash Flow | $-81 | $67 | $1,688 | $2,756 | $-7,986 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 1,331 | N/A | N/A | N/A |
| Debt Issued | N/A | 2,500 | N/A | N/A | 10,528 |
| Debt Repayment | -750 | N/A | N/A | -11 | -9,538 |
| Common Stock Issued | 6,019 | 39 | 5,856 | 21,601 | 4,952 |
| Other Financing Activity | -239 | -149 | -74 | -129 | 12,848 |
| Financing Cash Flow | $5,030 | $3,720 | $5,781 | $21,461 | $18,790 |
| Exchange Rate Effect | -1 | 0 | -209 | -240 | 263 |
| Beginning Cash Position | 12,702 | 11,237 | 11,785 | 2,674 | 19,752 |
| End Cash Position | 10,481 | 12,702 | 11,237 | 11,785 | 2,674 |
| Net Cash Flow | $-2,221 | $1,465 | $-549 | $9,112 | $-17,079 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,168 | -2,323 | -7,809 | -14,865 | -28,146 |
| Capital Expenditure | -85 | N/A | -71 | -375 | -1,029 |
| Free Cash Flow | -7,253 | -2,323 | -7,880 | -15,239 | -29,175 |